IgA nephropathy in adults—treatment standard

Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy

(2023) Fan Fan Hou et al.   JAMA Network Open

Long-Term Outcomes in IgA Nephropathy

(2023) David Pitcher et al.   Clinical Journal of the American Society of Nephrology

Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy

(2022) Jicheng Lv et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

(2022) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

(2022) et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Gliflozins in the Management of Cardiovascular Disease

(2022) Eugene Braunwald   NEW ENGLAND JOURNAL OF MEDICINE

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials

(2022) Colin Baigent et al.   LANCET

Empagliflozin in Patients with Chronic Kidney Disease

(2022)   NEW ENGLAND JOURNAL OF MEDICINE

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

(2021) David C. Wheeler et al.   KIDNEY INTERNATIONAL

Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

(2021) Brad H. Rovin et al.   KIDNEY INTERNATIONAL

Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers

(2020) Simon A. Carter et al.   Clinical Journal of the American Society of Nephrology

After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

(2020) Thomas Rauen et al.   KIDNEY INTERNATIONAL

TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy

(2020) Nuoyan Zheng et al.   JCI Insight

Dapagliflozin in Patients with Chronic Kidney Disease

(2020) Hiddo J.L. Heerspink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Perspectives on life participation by young adults with chronic kidney disease: an interview study

(2020) Jasmijn Kerklaan et al.   BMJ Open

Updating the International IgA Nephropathy Prediction Tool for use in children

(2020) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

(2019) Aliza Thompson et al.   Clinical Journal of the American Society of Nephrology

Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial

(2019) Li-Jun Liu et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study

(2019) Simon Jarrick et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

(2019) Sean J. Barbour et al.   JAMA Internal Medicine

TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy

(2019) Yuko Makita et al.   KIDNEY INTERNATIONAL

Epidemiology of IgA Nephropathy: A Global Perspective

(2018) Francesco Paolo Schena et al.   SEMINARS IN NEPHROLOGY

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

(2017) Jicheng Lv et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term efficacy of tonsillectomy as a treatment in patients with IgA nephropathy: a meta-analysis

(2016) Jiayu Duan et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

The MEST score provides earlier risk prediction in lgA nephropathy

(2016) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

Randomized Controlled Trial of Mycophenolate Mofetil in Children, Adolescents, and Adults With IgA Nephropathy

(2015) Ronald J. Hogg et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

(2015) Thomas Rauen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

(2014) Rosanna Coppo et al.   KIDNEY INTERNATIONAL

Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan

(2014) Takahito Moriyama et al.   PLoS One

Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease

(2013) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

IgA Nephropathy

(2013) Robert J. Wyatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Pathophysiology of IgA Nephropathy

(2011) H. Suzuki et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population

(2011) W. Le et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The incidence of primary glomerulonephritis worldwide: a systematic review of the literature

(2010) A. McGrogan et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-term study of mycophenolate mofetil treatment in IgA nephropathy

(2009) Sydney C.W. Tang et al.   KIDNEY INTERNATIONAL

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy

(2009) C. Manno et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Combination Therapy of Prednisone and ACE Inhibitor Versus ACE-Inhibitor Therapy Alone in Patients With IgA Nephropathy: A Randomized Controlled Trial

(2008) Jicheng Lv et al.   AMERICAN JOURNAL OF KIDNEY DISEASES